Jan 14, 2026
Which oral GLP‑1 and multi‑agonist drugs are nearest FDA approval and how might their costs differ from injectables?
Two oral GLP‑1 pills are effectively already at the finish line: Novo Nordisk’s oral semaglutide (Wegovy pill) received FDA approval in late 2025 with a U.S. launch planned for early January 2026, and...